Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain

Trends in Pharmacological Sciences

Volumn 27, Issue 12, 2006, Pages 646-651

  Campos, Maria M ^a,b   Leal, Paulo C ^a   Yunes, Rosendo A ^a   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 SULFAMOYLBENZAMIDE DERIVATIVE; 2,3 DIAMINOPYRIDINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BRADYKININ B1 RECEPTOR ANTAGONIST; DIHYDROQUINOXALINONE DERIVATIVE; LF 220542; NVPSSA 164; SSR 240612; UNCLASSIFIED DRUG; VELUTINOL A;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; CANCER; DIABETES MELLITUS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG POTENCY; DRUG RECEPTOR BINDING; HUMAN; HYPERALGESIA; INFECTION; INFLAMMATION; NEUROPATHIC PAIN; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; DIOXOLES; HUMANS; INFLAMMATION; MOLECULAR BIOLOGY; PAIN; RECEPTOR, BRADYKININ B1; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 33750953051     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2006.10.007     Document Type: Review

References (61)

1. Regoli D., and Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32 (1980) 1-46
2. Calixto J.B., et al. Inflammatory pain: kinins and antagonists. Curr. Opin. Anaesthesiol. 14 (2001) 519-526
3. Leeb-Lundberg L.M., et al. International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57 (2005) 27-77
4. Pesquero J.B., and Bader M. Genetically altered animal models in the kallikrein-kinin system. Biol. Chem. 387 (2006) 119-126
5. 9-bradykinin and susceptibility to inflammation. J. Biol. Chem. 278 (2003) 219-225
6. 1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br. J. Pharmacol. 143 (2004) 803-818
7. Ferreira J., et al. Reduced nerve injury-induced neuropathic pain in kinin B1 receptor knock-out mice. J. Neurosci. 25 (2005) 2405-2412
8. 1 receptor. Br. J. Pharmacol. 144 (2005) 889-899
9. Hock F.J., et al. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol. 102 (2001) 769-773
10. Trifilieff A., et al. Comparative action of new highly potent bradykinin receptor antagonists in the guinea-pig trachea. Eur. J. Pharmacol. 239 (1993) 227-229
11. 1 receptor antagonist. Eur. J. Pharmacol. 205 (1991) 217-218
12. 2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guerin (BCG). Br. J. Pharmacol. 120 (1997) 502-508
13. 1 receptor-related peptides. Antagonists. Hypertension 28 (1996) 833-839
14. Stewart J.M., et al. A new generation of bradykinin antagonists. Immunopharmacology 33 (1996) 51-60
15. 1 receptor antagonist. J. Am. Chem. Soc. 125 (2003) 7516-7517
16. 1 antagonists. J. Med. Chem. 46 (2003) 1803-1806
17. 1 receptor: biochemical and pharmacological characterization. J. Pharmacol. Exp. Ther. 309 (2004) 661-669
18. 1 receptor antagonists. J. Med. Chem. 47 (2004) 6439-6442
19. Marceau F., and Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nat. Rev. Drug Discov. 3 (2004) 845-852
20. Ritchie T.J., et al. Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide core. J. Med. Chem. 47 (2004) 4642-4644
21. 1 receptor antagonist. J. Pharmacol. Exp. Ther. 318 (2006) 195-205
22. Costa, R. et al. Effect of novel selective non-peptide kinin B(1) receptor antagonists on mouse pleurisy induced by carrageenan. Peptides (in press)
23. Ha S.N., et al. Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1. Biochem. Biophys. Res. Commun. 331 (2005) 159-166
24. 1 receptor antagonist. Eur. J. Pharmacol. 499 (2004) 77-84
25. 1 receptor antagonists. Bioorg. Med. Chem. Lett. 15 (2005) 2385-2388
26. 1 receptor antagonists. J. Med. Chem. 49 (2006) 1231-1234
27. Burgess G.M., et al. Bradyzide, a potent non-peptide receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia. Br. J. Pharmacol. 129 (2000) 77-86
28. Calixto J.B., et al. Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B (NF-kappaB). Planta Med. 69 (2003) 973-983
29. Calixto J.B., et al. Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med. 70 (2004) 93-103
30. Yunes R.A., et al. The structure of velutinol (A), an anti-inflammatory compound with a novel pregnane skeleton. Phytochem. Analysis. 4 (1993) 76-81
31. Calixto J.B., et al. The competitive antagonistic effect of compounds from Mandevilla velutina on kinin-induced contractions of rat uterus and guinea-pig ileum in vitro. Br. J. Pharmacol. 94 (1998) 1133-1142
32. 1 receptor-mediated responses. Regul. Pept. 136 (2006) 98-104
33. Mattos W.M., et al. Antinociceptive properties produced by the pregnane compound velutinol A isolated from Mandevilla velutina. Neuropeptides 40 (2006) 125-132
34. Couture R., et al. Kinin receptors in pain and inflammation. Eur. J. Pharmacol. 429 (2001) 161-176
35. Bhoola K., et al. Kallikrein and kinin receptor expression in inflammation and cancer. Biol. Chem. 382 (2001) 77-89
36. Moreau M.E., et al. The kallikrein-kinin system: current and future pharmacological targets. J. Pharmacol. Sci. 99 (2005) 6-38
37. 1 receptors for kinins. Pharmacol. Rev. 50 (1998) 357-386
38. 1 transgenic rat as a pharmacodynamic model. J. Pharmacol. Exp. Ther. 310 (2004) 488-497
39. 1 receptors. Br. J. Pharmacol. 144 (2005) 885-886
40. Regoli D., et al. Classification of kinin receptors. Biol. Chem. 382 (2001) 31-35
41. 1 receptor. Int. Immunopharmacol. 2 (2002) 1747-1754
42. 1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor. Mol. Pharmacol. 57 (2000) 171-179
43. 2) subtypes. FASEB J. 17 (2003) 73-75
44. 1 receptor up-regulation after lipopolysaccharide administration: role of proinflammatory cytokines and neutrophil influx. J. Immunol. 172 (2004) 1839-1847
45. 1 receptors in human pulmonary fibroblasts: role of intact pathogens and p38 mitogen-activated protein kinase-dependent signaling. J. Pharmacol. Exp. Ther. 313 (2005) 1231-1238
46. Bengtson S.H., et al. Kinin receptor expression during Staphylococcus aureus infection. Blood 108 (2006) 2055-2063
47. 2 receptors in allergen-induced bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 160 (1999) 1717-1723
48. 1 receptors in allergic airway inflammation. J. Immunol. 169 (2002) 2054-2060
49. Lavich T.R., et al. Combined action of vasoactive amines and bradykinin mediates allergen-evoked thermal hyperalgesia in rats. Eur. J. Pharmacol. 462 (2003) 185-192
50. Sugahara S., et al. Kinins are involved in the development of allergic nasal hyperresponsiveness in guinea pigs. Eur. J. Pharmacol. 476 (2003) 229-237
51. Gama Landgraf R., et al. Modulation of allergic and immune complex-induced lung inflammation by bradykinin receptor antagonists. Inflamm. Res. 53 (2004) 78-83
52. Abraham W.M., et al. Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease. Eur. J. Pharmacol. 533 (2006) 215-221
53. 1 receptor in the rat brain and alterations induced by diabetes in the model of streptozotocin. Synapse 57 (2005) 29-37
54. 1 receptor subtype: evidence in various experimental animal models of type 1 and type 2 diabetic neuropathy. Biol. Chem. 387 (2006) 127-143
55. Raidoo D.M., et al. Kinin receptors are expressed in human astrocytic tumour cells. Immunopharmacology 43 (1999) 255-263
56. Taub J.S., et al. Bradykinin receptor subtype 1 expression and function in prostate cancer. Cancer Res. 63 (2003) 2037-2041
57. Stewart J.M. Bradykinin antagonists as anti-cancer agents. Curr. Pharm. Des. 9 (2003) 2036-2042
58. Sainz I.M., et al. Interactions between bradykinin (BK) and cell adhesion molecule (CAM) expression in peptidoglycan-polysaccharide (PG-PS)-induced arthritis. FASEB J. 18 (2004) 887-889
59. 2 and neurokinin-1 receptor activation on endothelial cell proliferation in acute synovitis. FASEB J. 18 (2004) 762-764
60. 1 bradykinin receptors in inflammatory mechanical hyperalgesia. Pain 104 (2003) 683-691
61. Rashid M.H. Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice. J. Pharmacol. Exp. Ther. 308 (2004) 1158-1164